Dermira, Inc. (DERM): Price and Financial Metrics
DERM Price/Volume Stats
Current price | $3.68 | 52-week high | $8.11 |
Prev. close | $3.89 | 52-week low | $1.02 |
Day low | $3.65 | Volume | 99,000 |
Day high | $3.99 | Avg. volume | 190,456 |
50-day MA | $4.18 | Dividend yield | N/A |
200-day MA | $3.56 | Market Cap | 68.11M |
DERM Stock Price Chart Interactive Chart >
DERM Stock Summary
- JOURNEY MEDICAL CORP's stock had its IPO on November 12, 2021, making it an older stock than just 2.48% of US equities in our set.
- With a year-over-year growth in debt of -87.68%, JOURNEY MEDICAL CORP's debt growth rate surpasses merely 1.49% of about US stocks.
- The volatility of JOURNEY MEDICAL CORP's share price is greater than that of 94.69% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to JOURNEY MEDICAL CORP are SMLR, VNT, OPEN, EVLV, and BODY.
- To check out JOURNEY MEDICAL CORP's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001867066.
DERM Valuation Summary
- DERM's price/sales ratio is 1.3; this is 69.05% lower than that of the median Healthcare stock.
- DERM's price/sales ratio has moved down 2.1 over the prior 26 months.
Below are key valuation metrics over time for DERM.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
DERM | 2023-12-29 | 1.3 | 6.1 | -8.6 | -8.5 |
DERM | 2023-12-28 | 1.5 | 6.8 | -9.5 | -9.7 |
DERM | 2023-12-27 | 1.6 | 7.5 | -10.5 | -10.9 |
DERM | 2023-12-26 | 1.6 | 7.4 | -10.4 | -10.8 |
DERM | 2023-12-22 | 1.8 | 8.5 | -11.9 | -12.6 |
DERM | 2023-12-21 | 1.8 | 8.4 | -11.8 | -12.5 |
Dermira, Inc. (DERM) Company Bio
Dermira is a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients. The company was founded in 2010 and is based in Menlo Park, California.
Latest DERM News From Around the Web
Below are the latest news stories about JOURNEY MEDICAL CORP that investors may wish to consider to help them evaluate DERM as an investment opportunity.
Here's What Could Help Journey Medical Corporation (DERM) Maintain Its Recent Price StrengthJourney Medical Corporation (DERM) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen. |
The Zacks Analyst Blog Highlights Amphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive TherapeuticsAmphastar Pharmaceuticals, Journey Medical, Centessa Pharmaceuticals and Aquestive Therapeutics are part of the Zacks top Analyst Blog. |
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?Here are four drug, biotech stocks, AMPH, DERM, CNTA & AQST, which have more than doubled in 2023 with room for further growth in 2024. |
argenx (ARGX) Tanks on Top-Line Data From Pemphigus Studyargenx's (ARGX) phase III ADDRESS study, evaluating efgartigimod subcutaneous for treating pemphigus, fails to meet primary and secondary endpoints. Stock falls. |
Anavex (AVXL) Rises as CHMP Deems Blarcamesine Eligible for MAAThe CHMP agrees that Anavex's (AVXL) blarcamesine for Alzheimer's disease is eligible for submission for a Union Marketing Authorisation in the EU. Shares rise. |
DERM Price Returns
1-mo | -9.36% |
3-mo | -36.11% |
6-mo | 34.31% |
1-year | 187.50% |
3-year | N/A |
5-year | N/A |
YTD | -36.11% |
2023 | 200.00% |
2022 | -64.31% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Continue Researching DERM
Want to do more research on NA's stock and its price? Try the links below:NA (DERM) Stock Price | Nasdaq
NA (DERM) Stock Quote, History and News - Yahoo Finance
NA (DERM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...